Jared Rowe Smith bought $19k of POWW
CEO at AMMO, INC.. 8,000 shares at an average of $2.33, traded Feb 28, 2024, filed Mar 1, 2024.
Score components
- +25RoleCEO
- 0Trade size$19k at market
- 0Relative to holdingsHoldings up 2.5%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-24-008490, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 28, 2024 | POpen-market purchase Common Stock | +8,000 | $2.33 | $19k | 324,604 | Mar 1, 2024 |
Related signals
Other insiders at AMMO, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | POWWsell AMMO, INC. | Fred W Wagenhals EXECUTIVE CHAIR | $537k 221,138 shares | -3% | |
| 29Weak | POWWsell AMMO, INC. | Fred W Wagenhals EXECUTIVE CHAIR | $87k 36,289 shares | -0% | |
| 38Weak | POWWsell AMMO, INC. | Fred W Wagenhals EXECUTIVE CHAIR | $481k 192,573 shares | -3% | |
| 25Weak | POWWbuy AMMO, INC. | Jared Rowe Smith CEO | $20k 9,500 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.